The SpaceX IPO Is Over. History Says Investors Should Do This Next.

SpaceX completed a historic IPO at $135 per share, selling 555,555,555 shares and raising about $75 billion initially, with proceeds cited as near $86 billion as the market cap rose to roughly $2.5 trillion. The article argues IPO history is mixed: about 60% of IPO stocks had negative three-year returns, though for mature IPOs with at least $100 million in trailing revenue, the three-year loss rate was 48.8%. Overall, the piece frames SpaceX as a highly speculative, valuation-rich AI and Starship-driven story rather than a clear buy.

Analysis

The immediate second-order winner is not the named public comps themselves but the entire “AI infrastructure + high-duration growth” complex. A landmark mega-cap IPO at an extreme valuation tends to re-anchor investor willingness to pay up for optionality, which can temporarily compress the discount rate applied to other assets with similarly distant cash flows. That is supportive for NVDA and META near term, but only if the market continues rewarding narrative over cash conversion; once the novelty wears off, multiples should gravitate back toward execution quality rather than story premium.

The bigger risk is that this listing becomes a reference point for every future AI capex debate. If the market embraces the premise that orbital data centers and AI infrastructure can justify trillion-dollar outcomes, it may encourage a broader reopening of speculative issuance across pre-profit tech and “moonshot” venture-backed names. That is a setup for sharper post-debut reversals over the next 3–12 months if revenue monetization lags the implied roadmap; the valuation surface is fragile because expectations are now several years ahead of operating proof.

For the large public beneficiaries in the article’s peer set, the signal is mixed. TSLA and NVDA gain as sentiment proxies for frontier-tech risk appetite, while MORN is an underappreciated beneficiary on the advisory/market-data side if retail participation accelerates. By contrast, BRK.B, JPM, V, and WMT are likely to remain relative funding sources rather than direct beneficiaries: in a risk-on tape, capital rotates out of quality compounders into higher-beta narratives, which can create a temporary relative underperformance window without changing their fundamentals.

Contrarian view: the market may be overestimating how quickly scale and technology moats convert into durable equity value. A very high IPO price does not just imply confidence; it also raises the probability of post-listing supply overhang, lockup-related pressure, and a multi-quarter “prove it” reset. If execution milestones slip even modestly, downside could be convex because the current valuation leaves little room for a normal de-rating.

Key Decisions for Investors

• Fade the speculative read-through: short a basket of unprofitable AI/software names against long NVDA for 1-3 months if the post-IPO euphoria extends, targeting a 10-15% relative move as narrative premium normalizes.
• Add to META on weakness only; use the IPO as a sentiment tailwind, but keep sizing modest because the upside is second-order and likely capped to 5-8% unless ad spend re-accelerates.
• Sell 1-3 month out-of-the-money calls on TSLA into strength to monetize the risk-on impulse; the trade benefits if enthusiasm cools and implied volatility remains elevated.
• Long MORN on a 3-6 month horizon as a lower-beta beneficiary of retail attention and market participation; pair against JPM or BRK.B to isolate the sentiment premium with less fundamental beta.
• Avoid chasing any pre-profit AI/space-adjacent IPOs for now; wait for a 30-40% post-debut retrace or a credible monetization update before initiating long exposure.